Koch Industries Inc. reduced its position in shares of Danaher Co. (NYSE:DHR) by 54.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,520 shares of the conglomerate’s stock after selling 9,041 shares during the quarter. Koch Industries Inc.’s holdings in Danaher were worth $698,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the stock. Calton & Associates Inc. purchased a new stake in shares of Danaher in the fourth quarter worth approximately $114,000. First Personal Financial Services raised its stake in shares of Danaher by 128.9% in the fourth quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after purchasing an additional 691 shares during the last quarter. Zions Bancorporation raised its stake in shares of Danaher by 118.3% in the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after purchasing an additional 667 shares during the last quarter. Truewealth LLC purchased a new stake in shares of Danaher in the fourth quarter worth approximately $121,000. Finally, Resources Investment Advisors Inc. raised its stake in shares of Danaher by 661.2% in the fourth quarter. Resources Investment Advisors Inc. now owns 1,530 shares of the conglomerate’s stock worth $142,000 after purchasing an additional 1,329 shares during the last quarter. 77.83% of the stock is currently owned by institutional investors and hedge funds.
In other Danaher news, Director John T. Schwieters sold 10,578 shares of the stock in a transaction on Monday, February 26th. The stock was sold at an average price of $100.30, for a total transaction of $1,060,973.40. Following the completion of the transaction, the director now directly owns 29,531 shares of the company’s stock, valued at $2,961,959.30. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Daniel L. Comas sold 62,989 shares of the stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $101.96, for a total value of $6,422,358.44. Following the transaction, the chief financial officer now directly owns 227,805 shares of the company’s stock, valued at $23,226,997.80. The disclosure for this sale can be found here. Over the last three months, insiders have sold 313,260 shares of company stock valued at $31,657,786. 12.20% of the stock is owned by corporate insiders.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The business had revenue of $5.09 billion during the quarter, compared to analyst estimates of $4.97 billion. During the same period in the prior year, the company earned $1.05 earnings per share. Danaher’s revenue was up 10.9% compared to the same quarter last year. equities research analysts anticipate that Danaher Co. will post 4.37 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, March 29th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.63%. This is a positive change from Danaher’s previous quarterly dividend of $0.14. The ex-dividend date is Wednesday, March 28th. Danaher’s dividend payout ratio is 16.00%.
Several analysts have recently commented on DHR shares. Stifel Nicolaus increased their price objective on Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. Cowen reissued a “buy” rating and issued a $110.00 price objective on shares of Danaher in a research note on Tuesday, January 30th. UBS Group initiated coverage on Danaher in a research note on Monday, January 22nd. They issued a “buy” rating and a $99.97 price objective for the company. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a report on Friday, January 12th. Finally, Citigroup upped their target price on Danaher to $107.00 and gave the company a “buy” rating in a report on Friday, December 15th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $101.40.
ILLEGAL ACTIVITY WARNING: “Koch Industries Inc. Has $698,000 Stake in Danaher Co. (NYSE:DHR)” was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://stocknewstimes.com/2018/03/14/koch-industries-inc-lowers-holdings-in-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.